JP2022534494A5 - - Google Patents
Info
- Publication number
- JP2022534494A5 JP2022534494A5 JP2021570263A JP2021570263A JP2022534494A5 JP 2022534494 A5 JP2022534494 A5 JP 2022534494A5 JP 2021570263 A JP2021570263 A JP 2021570263A JP 2021570263 A JP2021570263 A JP 2021570263A JP 2022534494 A5 JP2022534494 A5 JP 2022534494A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- pharmaceutical composition
- variable region
- chain variable
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025168433A JP2026004525A (ja) | 2019-05-28 | 2025-10-06 | 抗ｃｄ４０抗体の安全な投与を提供する方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962853488P | 2019-05-28 | 2019-05-28 | |
| US62/853,488 | 2019-05-28 | ||
| PCT/IB2020/055023 WO2020240434A1 (en) | 2019-05-28 | 2020-05-27 | Method of providing safe administration of an anti-cd40 antibody |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025168433A Division JP2026004525A (ja) | 2019-05-28 | 2025-10-06 | 抗ｃｄ４０抗体の安全な投与を提供する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022534494A JP2022534494A (ja) | 2022-08-01 |
| JP2022534494A5 true JP2022534494A5 (https=) | 2023-06-05 |
| JP7755999B2 JP7755999B2 (ja) | 2025-10-17 |
Family
ID=70918772
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021570263A Active JP7755999B2 (ja) | 2019-05-28 | 2020-05-27 | 抗ｃｄ４０抗体の安全な投与を提供する方法 |
| JP2025168433A Pending JP2026004525A (ja) | 2019-05-28 | 2025-10-06 | 抗ｃｄ４０抗体の安全な投与を提供する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025168433A Pending JP2026004525A (ja) | 2019-05-28 | 2025-10-06 | 抗ｃｄ４０抗体の安全な投与を提供する方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20230174658A1 (https=) |
| EP (1) | EP3976651A1 (https=) |
| JP (2) | JP7755999B2 (https=) |
| KR (1) | KR20220012918A (https=) |
| CN (1) | CN113939535A (https=) |
| AU (1) | AU2020284706A1 (https=) |
| BR (1) | BR112021023906A2 (https=) |
| CA (1) | CA3142226A1 (https=) |
| IL (1) | IL288288A (https=) |
| MA (1) | MA56027A (https=) |
| MX (1) | MX2021014572A (https=) |
| SG (1) | SG11202112909SA (https=) |
| WO (1) | WO2020240434A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023122355A2 (en) * | 2021-12-24 | 2023-06-29 | Sapience Therapeutics, Inc. | Methods of treating or preventing infusion-related reactions |
| TW202342057A (zh) * | 2022-02-07 | 2023-11-01 | 美商健生生物科技公司 | 用於減少用ｅｇｆｒ／ｍｅｔ雙特異性抗體治療之患者的輸注相關反應之方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070003557A1 (en) * | 2005-04-21 | 2007-01-04 | Andres Forero | Method for treating cancer using premedication |
| GB201115280D0 (en) | 2011-09-05 | 2011-10-19 | Alligator Bioscience Ab | Antibodies, uses and methods |
| CA2957146A1 (en) * | 2014-08-12 | 2016-02-18 | Alligator Bioscience Ab | Combination therapies with anti cd40 antibodies |
| WO2018160917A1 (en) | 2017-03-03 | 2018-09-07 | Janssen Biotech, Inc. | Co-therapy comprising a small molecule csf-1r inhibitor and an agonistic antibody that specifically binds cd40 for the treatment of cancer |
-
2020
- 2020-05-27 AU AU2020284706A patent/AU2020284706A1/en active Pending
- 2020-05-27 EP EP20729226.9A patent/EP3976651A1/en active Pending
- 2020-05-27 CA CA3142226A patent/CA3142226A1/en active Pending
- 2020-05-27 CN CN202080039748.6A patent/CN113939535A/zh active Pending
- 2020-05-27 US US17/613,632 patent/US20230174658A1/en not_active Abandoned
- 2020-05-27 MA MA056027A patent/MA56027A/fr unknown
- 2020-05-27 KR KR1020217042271A patent/KR20220012918A/ko not_active Ceased
- 2020-05-27 BR BR112021023906A patent/BR112021023906A2/pt unknown
- 2020-05-27 SG SG11202112909SA patent/SG11202112909SA/en unknown
- 2020-05-27 MX MX2021014572A patent/MX2021014572A/es unknown
- 2020-05-27 WO PCT/IB2020/055023 patent/WO2020240434A1/en not_active Ceased
- 2020-05-27 JP JP2021570263A patent/JP7755999B2/ja active Active
-
2021
- 2021-11-22 IL IL288288A patent/IL288288A/en unknown
-
2025
- 2025-10-06 JP JP2025168433A patent/JP2026004525A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101948539B (zh) | Il-18结合蛋白 | |
| KR102171669B1 (ko) | 조합물 및 이의 용도 | |
| JP2022515770A5 (https=) | ||
| JP2003531129A5 (https=) | ||
| JP2020529469A5 (https=) | ||
| JP2024531151A5 (https=) | ||
| JP2022512722A (ja) | 抗ｃｄ３８抗体の皮下投与を提供する方法 | |
| JP2023548858A5 (https=) | ||
| MX2010010028A (es) | Agente para tratar enfermedad. | |
| JP2024001125A (ja) | Ｉｌ－１７アンタゴニストを用いて初発プラーク型乾癬を治療する方法 | |
| JP2022531408A5 (https=) | ||
| JP2012530132A (ja) | 多発性硬化症の治療のための組成物および方法 | |
| HK1213782A1 (zh) | 在诊断和治疗类风湿性关节炎中使用的包含抗-cd6单克隆抗体的药物组合物 | |
| JP2022513421A5 (https=) | ||
| JP2022528005A5 (https=) | ||
| AU2009296078B2 (en) | Composition for treating disease | |
| WO2018072743A1 (zh) | Pd-1抗体与ido抑制剂联合在制备抗肿瘤的药物中的用途 | |
| JP2023500337A5 (https=) | ||
| JP2022534494A5 (https=) | ||
| JP2024540226A5 (https=) | ||
| JP2020500161A5 (https=) | ||
| JP2023527054A5 (https=) | ||
| JP2022544050A5 (https=) | ||
| CN111166878A (zh) | 靶向肿瘤抗原的抗体与iNKT细胞的组合的制备方法与用途 | |
| JP2024528877A5 (https=) |